NCT07283848 2025-12-26
Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma
Massachusetts General Hospital
Phase 2 Withdrawn
Clinical Trials
29 trialsNCT04180761 2025-04-03
ProPeC
University Hospital Tuebingen
Phase 2 Withdrawn
NCT04863430 2025-02-21
Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach
Peking University
Phase 2 Withdrawn
NCT05471401 2024-06-13
GI Organ Tracking Via Balloon Applicators
Washington University School of Medicine
Phase NA Withdrawn
NCT05703555 2024-02-28
INTRUSION
Erasmus Medical Center
Phase 2 Withdrawn
NCT02519140 2023-12-04
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Maimonides Medical Center
Phase 3 Withdrawn
NCT04591028 2023-07-19
A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients
Mayo Clinic
Phase 4 Withdrawn
NCT04868747 2023-01-12
The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping
The Catholic University of Korea
Phase NA Withdrawn
NCT03563352 2020-12-14
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
University of Southern California
Withdrawn
NCT02919553 2020-10-20
Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions
Loma Linda University
Phase NA Withdrawn
NCT03554395 2020-10-19
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2 Withdrawn
NCT02713984 2020-03-19
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
Southwest Hospital, China
Phase 1/2 Withdrawn
NCT03644459 2020-03-11
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
Lynkcell Inc.
Phase 1 Withdrawn
NCT01470742 2019-12-30
Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
Samsung Medical Center
Phase 3 Withdrawn
NCT00387530 2019-08-02
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
University of California, San Diego
Phase 2 Withdrawn
NCT02736552 2019-05-08
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
Fudan University
Phase 3 Withdrawn
NCT01714622 2019-03-29
Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance
Yonsei University
Withdrawn
NCT02245971 2019-01-16
A Study on Precutting Methods of Endoscopic Submucosal Dissection for Gastric Neoplasms Located at Lesser Curvature Side of Antrum
Yonsei University
Phase NA Withdrawn
NCT02594943 2018-11-26
Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
Region Skane
Phase NA Withdrawn
NCT02943603 2018-07-13
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
University of Pittsburgh
Phase 2 Withdrawn
NCT01821196 2018-03-12
Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma
St. Olavs Hospital
Phase NA Withdrawn
NCT00588263 2018-02-19
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn
NCT02063412 2017-02-02
Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens
Chinese University of Hong Kong
Withdrawn
NCT02334332 2015-09-25
Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery
City of Hope Medical Center
Phase NA Withdrawn
NCT00017537 2013-08-05
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
University of Alabama at Birmingham
Phase 1 Withdrawn
NCT00025532 2012-09-14
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
University of California, San Francisco
Phase 1 Withdrawn
NCT01031056 2012-05-28
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Stanford University
Withdrawn
NCT00429078 2012-03-02
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer
Roger Williams Medical Center
Phase 1 Withdrawn
NCT00209612 2009-02-17
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Withdrawn